Cervical Cancer

Regulator Evaluated In HIV Infected Women

Published in Women's Health Weekly, October 18th, 2001

Clinical investigators from the Institute of Human Virology (IHV) at the University of Maryland Biotechnology Institute and the University of Maryland, Baltimore, presented interim data from an ongoing clinical trial of CEL-SCI Corporation's investigational therapy, Multikine, at the Annual Meeting of the International Society for Interferon and Cytokine Research.

The meeting was held in Cleveland, Ohio from October 7-11, 2001.

The focus of this clinical study is on HIV infected women with human papillomavirus (HPV) induced cervical dysplasia, the precursor stage before the development of cervical cancer. Cervical cancer is the second leading cause...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2001-10-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry